Business Programme

16 March 09:30–10:45
 Lomonosov Cluster of the Sparrow Hills ISTC of Moscow State University, 1st floor, conference hall 2
Broadcast
Innovations in Pharmacology: The Intellectual Foundation of the Healthcare of the Future
Early Risk Medicine and Rehabilitation The development of new drugs not only ensures a quantum leap in disease treatment, but also promotes the development of new manufacturing processes and significantly influences the transformation of the entire patient care system by fundamentally shifting the therapeutic paradigm. Modern medical science has seen breakthrough developments in personalized medicine, particularly in cell therapy. Today, innovative CAR-T cell therapy is not only being successfully used in oncohematology, but is also steadily transitioning to the first clinical cases involving the immunoediting of malignant tumours, therapy for numerous autoimmune conditions, and treatment for type 1 diabetes, offering a chance to patients for whom standard treatments have proven ineffective. While this is not yet a new standard of therapy, these fundamental discoveries are being turned into clinical solutions that form the basis for new therapeutic strategies. Scientific research is focused on expanding the use of CAR-T therapy, reducing relapses and side effects, and increasing the length of remission. In what sectors is pharmaceutical innovation most rapidly developing today? How is the creation of new drugs changing approaches to patient care and leading to new standards in pharmaceutical manufacturing? What is the current state of cell therapy development, and what obstacles are limiting this progress? What regulatory tools are needed to actively introduce pharmaceutical innovations into clinical practice? What areas of medicine will have potential for CAR-T therapy in the near future?
Moderator:
Аlexander Rumyantsev — President, Dmitry Rogachev National Research Center of Pediatric Hematology,Oncology and Immunology
Alexander Rumyantsev, born in 1947, is a Russian Doctor of Medical Sciences, professor, member of the Russian Academy of Sciences, General Director of the Dmitry Rogachev National Research Centre of Pediatric Hematology, Oncology and Immunology, member of the Board of the ‘Doctors, Innovation and Science for Children’ Foundation that supports the development of Pediatric Hematology, Oncology and Immunology, chief consulting pediatric hematologist of the Ministry of Health of Russia, President of the National Society of Pediatric Hematologists and Oncologists, Chairman of the Board of the National Association of Experts in Primary Immunodeficiency, Vice President of the National Medical Chamber, Honorary Professor of the Department of Oncology and Hematology of the School of Pediatrics of Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation. Graduated with honours from the Russian National Research Medical University named after N.I. Pirogov in 1971.
Alexander Rumyantsev is an active facilitator of medical science and practice. For years he headed the RSMU scientific programmes on leukemia in humans and animals of the USSR Committee for Science and Technology and research on rectifying the consequences of Chernobyl disaster, was a member of the Academic Council of the Academy of Medical Sciences and the Ministry of Health of the USSR on pediatrics, hematology and oncology. From 1989 to the present day he has been a Chairman of the hematology section of the Moscow Society of Pediatric Physicians. He is a participant of the Chernobyl nuclear disaster elimination team (1986–1987), ‘Children of Chernobyl’ research programme facilitator in the USSR (1990–1991) and in Russia (1991–1995). Rumyantsev for twenty five years has led pediatric hematology/oncology services in Russia, the process of preparation and adoption of the industry development and financing programme, successful treatment of leukemia, malignant lymphomas, brain tumours, other neoplasms in children and adolescents, setting up a course on pediatric hematology/oncology in the School of Continuing Medical Education in RSMU (the Department of Clinical Hematology/Oncology and Immunology of the School of Continuing Medical Education in RSMU since 2004, and the Department of Oncology and Hematology of the School of Pediatrics of the RSMU), the groundwork for academic programme, the training and certification of pediatric hematologists/oncologists in the Russian Federation.
As a researcher, Alexander Rumyantsev is known for his works in pediatric hematology and immunology, medical ecology, intensive and outpatient pediatrics, adolescent medicine and organization of public health, clinical physiology and pathophysiology of blood, regulation of hematopoiesis and immune response, pathogenesis and treatment of hereditary and evoked blood diseases in children, intensive polychemotherapy and immunotherapy of leukemia. Alexander Rumyantsev is the author of more than 650 scientific papers, including 45 monographs and manuals. He is a member of the Scientific Council and the head of the scientific platform ‘Oncology’ of the Ministry of Health of the Russian Federation, the editor-in-chief of the Bulletin of Blood Service in Russia journal, a member of editorial boards of the following journals: Pediatrics, Russian Pediatric Journal, Issues of Practical Pediatrics, Issues of Dietary Therapy In Pediatrics, Issues of Hematology/Oncology And Immunopathology In Pediatrics, Hematology And Transfusiology, Russian Journal of Pediatric Hematology and Oncology, School of Health, Russian Journal of Immunology; member of the Pharmaceutical Committee of the Russian Federation; member of the National Council of Experts on Rare Diseases, advised 70 doctors and 128 candidates of medical sciences. Honourable Laureate of the Russian National Research Medical University awards (1978, 1983, 1994, 2007), of the Maslov Academy of Medical Sciences of the USSR (1978), of the Moscow Komsomol (1979) for the research in hematology and immunology. He was awarded with a participant’s diploma and a silver medal of the VDNKh (All-Union Exhibition of Achievements of National Economy) (1989) for development of diagnostics and immunotherapy of blood diseases in children, and with an honorary medal of the University of Montpellier (France, 1990). In 1994 he was awarded the Order of Friendship of Peoples for his scientific and academic work, in 2002 – the Honorary Diplomas of the State Duma of the Russian Federation and the Moscow City Duma, in 2003 and 2015 – ‘The Calling’ Award for the best doctors in Russia, in 2004 – the medal ‘For Merits in Healthcare’, in 2007 – Excellent Worker of Public Health badge. In 2008 and 2011 he received the medical awards from the Moscow government, in 2013 – the International Galien Award. In 2015 he was awarded the Glory of Ossetia Order and the Russian Emergencies Ministry (EMERCOM) medal ‘Cooperation for Salvation’.
Married with two children and five grandchildren.
Speakers:
Sergey Glagolev — Deputy Minister of Health of the Russian Federation
Kim Young Deug — Chief Technology Officer, TS Bio Co (online)
Valentina Kosenko — Acting General Director, Scientific Centre for Expert Evaluation of Medicinal Products of the Ministry of Health of the Russian Federation
Alexander Kulagin — Director, R.M. Gorbacheva Research Institute of Pediatric Oncology, Hematology, and Transplantology; Vice-Rector for Research, First Pavlov State Medical University of St. Petersburg, Ministry of Health of the Russian Federation
Vitaly Omelyanovskiy — General Director, Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation
Born July 27, 1964 in Obninsk, Kaluga Oblast.
In 1987, he graduated from the Pirogov Russian National Research Medical University with a degree in General Medicine. After graduation he stayed in the university, where he rose from postgraduate to professor of the department of clinical pharmacology.
In 1998 he graduated from the Russian Presidential Academy of National Economy and Public Administration of the Russian Federation with a degree in state and municipal management, with the qualification of economist-financier.
In 2002, he defended the first doctoral dissertation in the Russian Federation on clinical and economic analysis and pharmacoeconomics.
From 2009 to 2012 he was. - Vladimir Potanin was Director of the Research Institute for Clinical and Economic Expertise and Pharmacoeconomics at the N.I. Pirogov Russian National Research Medical University, Federal State Autonomous Educational Institution of Higher Professional Education, Ministry of Health Care of the Russian Federation.
From 2012 to 2020, she was Head of the Research Laboratory of the N.I. Pirogov Russian National Research Medical University. - Head of the Research Laboratory for Technology Assessment in Healthcare at the Institute of Applied Economic Research of the Russian Presidential Academy of National Economy and Public Administration, a federal state budget-funded educational institution of higher education.
Since 2014. - Head of the Healthcare Finance Center of the Federal State Budgetary Institution "Research Financial Institute" of the Ministry of Finance of the Russian Federation. Ministry of Finance of the Russian Federation.
Since 2015. - General Director of the Federal State Budgetary Institution "Center for Expertise and Quality Control of Medical Care" of the Ministry of Health of the Russian Federation.
Since 2020. - Head of the Department of Economics, Management and Assessment of Healthcare Technologies of the Federal State Budgetary Educational Institution of Additional Professional Education "Russian Medical Academy of Continuing Professional Education" of the Ministry of Healthcare of the Russian Federation.

Member of the Dissertation Council D 208.088.01.
Head of the Expert Council on Health Care of the Federation Council Committee on Social Policy, Expert of the Analytical Centre for the Government of the Russian Federation.
Chief Clinical Pharmacologist, Ministry of Health, Moscow Region.
Chief editor of scientific journals, Pharmacoeconomics. Modern Pharmacoeconomics and Pharmacoepidemiology" and "Medical Technology. Evaluation and Choice".
She is an author of three patents of the Russian Federation, two monographs, educational and methodical manuals for physicians, and more than 140 scientific papers published in Russian and foreign medical journals.
Doctor of Medicine (2002), Professor (2007). Under his supervision V.V. Omelyanovsky defended one doctoral thesis and seven Ph. Currently supervises the theses of two doctoral students and two doctoral candidates.
He is the President of the Russian branch of the International Society for Pharmacoeconomic Research and Outcome Evaluation (ISPOR).
He is a laureate of the Russian Federation Government Award in Science and Technology, has certificates of merit from the President of the Russian Federation and the Chairman of the Federation Council of the Federal Assembly of the Russian Federation, and has received commendations from the Chairman of the Federation Council of the Federal Assembly of the Russian Federation, the Analytical Center of the Russian Federation Government, the Russian Academy of National Economy and Public Administration under the President of the Russian Federation, and the Sverdlovsk Oblast Government.
Alexander Petrovskiy — Deputy Director for Educational Activities, N.N. Blokhin National Medical Research Center of Oncology оf the Ministry of Health of the Russian Federation
Peter Shegay — Deputy Director General for Science, National Medical Research Center for Radiology, Ministry of Health of the Russian Federation
16 March 15:45–17:00
 Lomonosov Cluster of the Sparrow Hills ISTC of Moscow State University, 3rd floor, conference hall 4
Broadcast
Diabetes under Control: Modern Solutions for Patients
Early Risk Medicine and Rehabilitation Advances in modern medicine are dramatically extending the lives of people with diabetes and improving their quality of life. Since 2023, Russia has prioritized the fight against diabetes with a special federal project that emphasizes strategies to prevent the progression of the disease with a focus on early stages and preclinical risks. Coordinated efforts by the government, medical community, and public sector need to focus on common goals in order to establish the systemic practice of implementing federal initiatives at the regional level. Which diagnostic technologies are most effective for the early detection of prediabetes and primary prevention? Which digital services and personalized monitoring technologies can improve the effectiveness of diabetes management, and how can they be integrated into patients’ daily lives to improve compliance? What educational and motivational practices can foster sustainable healthy lifestyle habits in people with risk factors? How can Russia develop a unified strategy for the prevention and early detection of diabetes for all regions of the country?
Moderator:
Inna Svyatenko — Deputy Chairman of the Federation Council of the Federal Assembly of the Russian Federation
Speakers:
Ksenia Abramova — Minister of Health of the Tver Region
Petr Bely — Founder and Chairman of the Board of Directors, Promomed Group
Founder and Chairman of the Board of Directors of Promomed Group, medical doctor. Petr Bely has more than 25 years of experience in the medical sector and has held senior positions in a number of large pharmaceutical companies. In 2005, he established the Promomed company and in a few years turned it into one of the most dynamically growing players in the Russian pharmaceutical market. Petr Bely regularly participates in scientific forums, conferences and other industry events. He is the author of numerous scientific publications. In March 2021, he was awarded the Pirogov Order for his merits in the field of drug production.

Education:

— Moscow State Medical and Dental University, "Medicine" specialty, training in clinical residency and a full course in "Therapeutics" specialty;
— Candidate of Medical Sciences in the "Internal diseases" specialty.
Evgeny Kamkin — Deputy Minister of Health of the Russian Federation
Anastasia Martynova — Head, Department of Health of the Government of the Jewish Autonomous Region
Natalia Mokrysheva — Director, I.I. Dedov National Medical Research Center of Endocrinology of the Ministry of Health of the Russian Federation; Academician, Russian Academy of Sciences
Anastasia Stolkova — First Deputy Director for Development, Roscongress Foundation; Member of the Commission of the Public Chamber of the Russian Federation on Healthcare
First Deputy Chief Executive Officer for Development, Director of the Healthcare Directorate of the Roscongress Foundation, Head of the Healthy Life and Women for a Healthy Society projects.

Public figure, member of the Regional Health Council of the Federation Council of the Federal Assembly of the Russian Federation, member of the Council of the Eurasian Women's Forum, public representative of the Agency for Strategic Initiatives.

Education:

Financial University under the Government of the Russian Federation, Master's degree in Economics, International Finance and Banking programme.

I.M. Sechenov First Moscow State Medical University, Master's degree in Public Health, Institute of Leadership and Health Management.

Since 2018, she has served as the Head of Healthcare at the Roscongress Foundation and is the creator of the Healthy Life project, which has become the primary platform for healthcare discussions at key business events, including the St. Petersburg International Economic Forum, the Eastern Economic Forum, and others. Over the years, the Healthy Life project has evolved into a multidisciplinary platform for national and international cooperation between government authorities and expert communities to collaboratively explore practical proposals for addressing critical healthcare issues. The Healthy Life Forum is held annually (in 2023, it was conducted as a summit of health ministers from CIS countries).

Since 2021, she has been managing the leading industry event, ‘Ensuring Drug Security’ Russian Pharmaceutical Forum, within the framework of the St. Petersburg International Economic Forum.

In 2021, she launched the Women for a Healthy Society project with the goal of uniting women who are involved in social projects within the health sector. This initiative is being carried out with the support of the Council of the Eurasian Women's Forum. The Women for a Healthy Society project is primarily focused on strengthening the values of health and the institution of the family in the Russian Federation. It aims to support initiatives led by women in the social sphere, which promote healthy lifestyles, provide assistance to motherhood and childhood, and offer support to the older generation.

In 2020, she received a letter of thanks from the President of the Russian Federation for her active participation in the preparation and organization of the Russia–Africa Summit and Economic Forum in 2019.

Also in 2020, she received a letter of thanks from the President of the Russian Federation for her selfless contribution to the Russian nationwide aid campaign We Are Together. This campaign aimed to provide social support to citizens during the COVID-19 epidemic in the Russian Federation.

In 2021, she received a letter of thanks from the Chairman of the Federation Council of the Federal Assembly of the Russian Federation for her great contribution to the preparation and organization of the Third Eurasian Women's Forum.

In 2022, she was awarded the Certificate of Honour of the Public Chamber of the Russian Federation for her outstanding contribution to healthcare and active citizenship.

In 2023, she received a letter of thanks from the Chairman of the Federation Council of the Federal Assembly of the Russian Federation for her contribution to the development of the Eurasian Women's Forum projects.

Also in 2023, she received a Commendation from the President of the Russian Federation for her contribution to the preparation and organization of the 25th St. Petersburg International Economic Forum.
Front row participant:
Konstantin Bobrakov — Head of the Department of Health, Government of the Oryol Region
Konstantin Bobrakov – Member of the Government of the Oryol Region — Head of the Department of Health of the Oryol Region; Candidate of Medical Sciences, Associate Professor of the Department of Public Health, Health Care and Hygiene of the Medical Institute, Advisor to the Administration of the Federal State Budgetary Educational Institution of Higher Education "Oryol State University named after I.S. Turgenev"
16 March 15:45–17:00
 Lomonosov Cluster of the Sparrow Hills ISTC of Moscow State University, 1st floor, conference hall 2
Broadcast
How to Keep Your Heart Healthy
Early Risk Medicine and Rehabilitation Russia’s state guarantees programme for 2026–2028 has expanded its capabilities for the early diagnosis of cardiovascular risks, and work is under way to improve drug provisions for patients at high risk for vascular emergencies. An individual’s conscious behaviour can account for a significant portion of his/her success in combatting cardiovascular disease. The key ingredients for a healthy heart include timely preventive care and a healthy lifestyle: physical activity, nutrition, monitoring your indicators, avoiding bad habits, stress management, as well as a high level of patient engagement in the treatment process and strict adherence to any prescribed therapy. What innovations in cardiology are enhancing the effectiveness of the fight against circulatory diseases? What changes have been made to the state guarantees programme to provide free cardiac care? What measures are included in the government’s strategies to reduce risk factors? How can we ensure the public is committed to preventive care and a healthy lifestyle? How can we improve patient compliance and bolster the paradigm of collaboration between doctors and patients?
Moderator:
Andrey Tyazhelnikov — Chief Doctor, City Polyclinic № 220 of the Department of Health of the City of Moscow; Chief External Specialist in Primary Health Care for the Adult Population
Doctor of Medical Sciences
Speakers:
Elena Golukhova — Director, A.N. Bakulev National Medical Research Center for Cardiovascular Surgery of the Ministry of Health of the Russian Federation; Chief Visiting Specialist in Arrhythmologist of the Ministry of Health of the Russian Federation
Simon Matskeplishvili — Deputy Director for Innovation Activities, Lomonosov Moscow State University Clinic; Member of the Board, Russian Society of Cardiology
Simon Matskeplishvili, MD, PhD, FESC, FACC, is a Professor of Cardiology and a Chief Scientific and Clinical Researcher at the Bakoulev Scientific Center for Cardiovascular Surgery in Moscow and an adjunct professor of life sciences at the Moscow Institute of Physics and Technology.
He also serves as a member of the Education, Certification and Accreditation, European Communities Committees of the European Association of Cardiovascular Imaging.
He graduated with honors from the Moscow Medical Academy in 1994 and had his postgraduate training and fellowship in cardiology at the Clinico-Diagnostic Department of the Bakoulev Center.
In 1997-1998 he received a degree of the International Master in Cardiology from the Institute of Clinical Physiology of the National Research Council of Italy in Pisa.
Simon Matskeplishvili is a Fellow of the European Society of Cardiology and a Fellow of the American College of Cardiology. He has received numerous honours and awards, both in Russia and internationally, including the European Cardiology award in 2001. He is a founder and a Chairman of the echocardiography section of the Russian society of cardiology. In 2007 he became a full professor of cardiology.
For the development of new non-invasive method of intracardiac blood flow evaluation in 2012 he was awarded a State Prize of the Government of Russian Federation in science and technology.
In 2013 he was a captain of the Russian team to win an ESC Cardiology Quiz “Primus inter pares” at the European Congress of Cardiology in Amsterdam.
In 2012 Professor Simon Matskeplishvili had organized and implemented the Educational Program for cardiologists and internal medicine physicians in Moscow. He also conducts an English-language elective course “Amazing Cardiology” in cardiology, cardiac surgery and cardiovascular imaging at the Faculty of Medicine of the Lomonosov Moscow State University.
The Board of the European Society of Cardiology has appointed Simon Matskeplishvili as the Coordinator of the Congress Programme Committee of the European Society of Cardiology Congress 2015-2016.
Ekaterina Milova — Development Director, ORBI Anti-Stroke Foundation
Viktor Fomin — Rector, Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation
Evgeny Shlyakhto — General Director, Almazov National Medical Research Centre of the Ministry of Health of the Russian Federation; Chief Visiting Cardiologist Specialist of the Ministry of Health of the Russian Federation
Professor Evgeny Shlyakhto, Director General of the Almazov National Medical Research Centre, Academician of the Russian Academy of Science, President of the Russian Society of Cardiology, Fellow of the European Society of Cardiology, the American Heart Association, and the American College of Cardiology.
Professor Shlyakhto was born on June 29, 1954 in Pogar, the Bryansk region. He graduated from the Pavlov Medical University in Saint Petersburg in 1977 and became Doctor of Science in Medicine in 1992, Professor in 1994, Honored Russian Scientist in 2004, and Academician of the Russian Academy of Sciences in 2014.
Evgeny Shlyakhto has been the Director General of the Almazov National Medical Research Centre since 2001 and the President of the Russian Society of Cardiology since 2011. In 2010, he became a member of the WHO Expert Working Group.
The Centre led by Prof. Shlyakhto carries out intensive research in the fields of translational medicine, molecular diagnostics, development of diagnostic tools for personalized treatment, cellular and tissue engineering for therapeutic purposes, creation of biocompatible materials and tissue-engineered constructs designed to create breakthrough medical technologies of fundamental importance for providing high-tech care to patients with cardiovascular, endocrine and blood diseases.
The results of research work by Prof. Shlyakhto have been summarized in more than 800 publications, 16 inventions, 2 scientific discoveries, and a number of monographs. Prof. Shlyakhto was a supervisor in 57 PhD and 20 DSc students..
Professor Shlyakhto is a member of the Presidium of the Russian Academy of Science, the Presidential Council for Science and Education, the Regional Health Council under the Federation Council of the Russian Federal Assembly, the Expert Health Council of the Federation Council Committee on Social Policy of the Russian Federal Assembly, Vice President of the National Medical Chamber.
Evgeny Shlyakhto is the Editor-in-Chief of the following medical journals: Russian Journal of Cardiology, Translational Medicine, and Journal of Arrhythmology. He also is a member of the international editorial board of the European Heart Journal.
Professor Shlyakhto plays an active role in such international committees as the ESC Congress Programme Committee (since 2012) and of the ESC Committee for Practice Guidelines (since 2015).
Evgeny Shlyakhto received the Russian Federation Government Prize in science and technology in 2009 and won the Pavlov Award, the prize for scientific and technological achievement in Physiology and Medicine from the Saint Petersburg Government and St. Petersburg Scientific Center of the Russian Academy of Sciences, in 2011. He received an Order of Honour in 2012 and 4th class Order of Merit for the Motherland in 2017.